FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder

BioticsAI's FDA approval for its AI-powered ultrasound diagnostic tool demonstrates that healthcare technology requires a fundamentally different development approach than consumer software—integrating regulatory strategy, clinical validation, and product development from inception rather than retrofitting compliance later. IT leaders must recognize that healthcare innovation investments demand extended timelines, higher governance standards, and cross-functional alignment between technical teams and clinical stakeholders, fundamentally changing project planning and risk management frameworks. This shift has profound implications for enterprise healthcare IT modernization initiatives: organizations adopting AI and emerging technologies in clinical settings must adopt similar integrated governance models and prepare infrastructure for longer deployment cycles while managing stakeholder expectations across medical, compliance, and technical domains.